Evidence map›Paper›PMID 32286360›Full record

ArticleScientific reports2020

Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease.

Amanda Torrentes-Carvalho, Juan Camilo Sánchez-Arcila, Tamiris Azamor, Luciana Santos Barbosa, Eugênio Damaceno Hottz, Mariana Gandini, Fernando Augusto Bozza, Rivaldo Venâncio da Cunha, Luzia Maria de Oliveira Pinto, Paulo Vieira Damasco and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Flow Cytometry as Immunoassay Tool for Research on Yellow Fever Virus.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Amanda Torrentes-CarvalhoDepartamento de Imunobiologia, Instituto de Biologia -Universidade Federal Fluminense (UFF), Niterói, Brazil.
Juan Camilo Sánchez-ArcilaLaboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Tamiris AzamorLaboratório de Tecnologia Imunológica - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Luciana Santos BarbosaLaboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Eugênio Damaceno HottzLaboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Mariana GandiniLaboratório de Microbiologia Celular, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-3603-6921
Fernando Augusto BozzaLaboratório de Medicina Intensiva, Intituto Nacional de Infectologia Evandro Chagas-INI, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Rivaldo Venâncio da CunhaUniversidade Federal do Mato Grosso do Sul (UFMS), Faculdade de Medicina, Campo Grande, Mato Grosso do Sul, Brazil.
Luzia Maria de Oliveira PintoLaboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Paulo Vieira DamascoHospital Universitário Gafreé & Guinle, Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil; Hospital Pedro Ernesto, Universidade Estadual do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Elzinandes Leal de AzeredoLaboratório de Imunologia Viral, Instituto Oswaldo Cruz (IOC) - Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil. elzinandes@ioc.fiocruz.br.
Fundação Oswaldo Cruz · BRHospital Universitário Pedro Ernesto · BRUniversidade Federal de Mato Grosso do Sul · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) co-circulation in Brazil represents a challenge for treatment and vaccine development. Despite public health impact, the occurrence of coinfections with other viruses is a common event. Increased T cell activation and altered inflammatory response are found during DENV coinfection with Human Immunodeficiency Virus (HIV) impacting HIV-pathogenesis. Even with Antiretroviral therapy (ART), HIV- treated patients had chronic immune activation and lymphocyte apoptosis. However, apoptotic mechanisms have not been investigated during coinfection with DENV. Our attention was attracted to apoptotic cell markers expressions in PBMCs from DENV and DENV/HIV coinfected patients. We found CD4/CD8 ratio inversion in most coinfected patients. CD4 T and CD8 T-cell subsets from DENV and DENV/HIV groups expressed low levels of anti-apoptotic protein Bcl-2. Furthermore, CD8 CD95 double positive cells frequency expressing low levels of Bcl-2 were significantly higher in these patients. Additionally, the density of Bcl-2 on classical monocytes (CD14

Indexed as

Acute DiseaseAdultAgedApoptosisBrazilCD4-CD8 RatioCD8-Positive T-LymphocytesCoinfectionDengueDengue VirusFemaleHIVHIV InfectionsHumansLeukocytes, MononuclearLymphocyte ActivationBCL2 protein, humanProto-Oncogene Proteins c-bcl-2

Identifiers

PMID32286360
PMCPMC7156518
OpenAlexW3015830451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.